Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-DOTA-TATE vs 68Ga-DOTA-JR11 in TIO
NCT04689893Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Mar 2020
- Primary completion
- Mar 2021
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Peking Union Medical College Hospital. Primary endpoint: Diagnostic value at 1 year. Status: unknown.
Beyond the preview
Go deeper on NCT04689893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04689893.